Hanninen, M., Venner, P. and North, S. (2013) “A rapid PSA half-life following docetaxel chemotherapy is associated with improved survival in hormone refractory prostate cancer”, Canadian Urological Association Journal, 3(5), pp. 369–74. doi: 10.5489/cuaj.1145.